Inflammatory markers in acute exacerbations of obstructive pulmonary disease:: predictive value in relation to smoking history

被引:6
作者
Dahlén, I
Janson, C
Björnsson, E
Stålenheim, G
Peterson, CGB
Venge, P
机构
[1] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[2] Uppsala Univ, Asthma Res Ctr, Uppsala, Sweden
[3] Pharmacia & Upjohn Diagnost AB, Uppsala, Sweden
关键词
D O I
10.1016/S0954-6111(99)90043-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to investigate the relationship between the effect of emergency treatment and inflammatory markers in patients with acute exacerbations of obstructive pulmonary disease, especially with respect to smoking history. We investigated 50 unselected patients with acute bronchial obstruction. Blood, urine and sputum samples were taken and analysed for eosinophil and neutrophil markers. The patients were observed for at least 2 h and recordings of forced expiratory volume in 1 s (FEV1) were taken. They were re-examined after 1 and 4 weeks. The absolute levels of inflammatory markers did not differ significantly between non- or short-term smokers (less than or equal to 5 pack-years) and long-term smokers (> 5 pack-years) with the exception of myeloperoxidase in serum (S-MPO), which was higher in long-term smokers. The patients with higher levels of eosinophil markers before emergency treatment experienced a greater improvement in lung function. In non- or short-term smokers this relationship was found in blood and urine, whereas in long-term smokers it was seen in sputum. No correlation was found between neutrophil markers and changes in lung function. We conclude that patients with obstructive pulmonary disease with acute exacerbations and high levels of eosinophil markers respond well to treatment. (C) 1999 HARCOURT PUBLISHERS LTD.
引用
收藏
页码:744 / 751
页数:8
相关论文
共 34 条
[1]   Eosinophil peroxidase: A new serum marker of atopy and bronchial hyper-responsiveness [J].
Bjornsson, E ;
Janson, C ;
Hakansson, L ;
Enander, I ;
Venge, P ;
Boman, G .
RESPIRATORY MEDICINE, 1996, 90 (01) :39-46
[2]   EOSINOPHILIC INFLAMMATION IN ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
LACOSTE, JY ;
BARNEON, G ;
GHAVANIAN, N ;
ENANDER, I ;
VENGE, P ;
AHLSTEDT, S ;
SIMONYLAFONTAINE, J ;
GODARD, P ;
MICHEL, FB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1033-1039
[3]  
CARLSON MGC, 1985, J IMMUNOL, V134, P1875
[4]   Corticosteroid reversibility in COPD is related to features of asthma [J].
Chanez, P ;
Vignola, AM ;
OShaugnessy, T ;
Enander, I ;
Li, DC ;
Jeffery, PK ;
Bousquet, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (05) :1529-1534
[5]   QUANTITATION OF MAST-CELLS AND EOSINOPHILS IN THE BRONCHIAL-MUCOSA OF SYMPTOMATIC ATOPIC ASTHMATICS AND HEALTHY CONTROL SUBJECTS USING IMMUNOHISTOCHEMISTRY [J].
DJUKANOVIC, R ;
WILSON, JW ;
BRITTEN, KM ;
WILSON, SJ ;
WALLS, AF ;
ROCHE, WR ;
HOWARTH, PH ;
HOLGATE, ST .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (04) :863-871
[6]  
*EUR COMM COAL STE, 1983, CLIN RESPIR PHYSL, V19, pS22
[7]   CELLULAR AND BIOCHEMICAL-ANALYSIS OF INDUCED SPUTUM FROM ASTHMATIC AND FROM HEALTHY-SUBJECTS [J].
FAHY, JV ;
LIU, J ;
WONG, H ;
BOUSHEY, HA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (05) :1126-1131
[8]  
Grebski E, 1998, EUR RESPIR J, V11, P734
[9]   THE ROLE OF THE EOSINOPHIL IN ASTHMA [J].
HOLGATE, ST ;
ROCHE, WR ;
CHURCH, MK .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (03) :S66-S70
[10]   BLOOD EOSINOPHIL COUNT AS RISK FACTOR FOR RELAPSE IN ACUTE ASTHMA [J].
JANSON, C ;
HERALA, M .
RESPIRATORY MEDICINE, 1992, 86 (02) :101-104